• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B7-H3通过CCR5高表达的肿瘤相关巨噬细胞促进乳腺癌的侵袭和转移

Promotion of the invasion and metastasis of breast cancer by B7-H3 through CCR5High tumor-associated macrophages.

作者信息

Dai Tiantian, Xu Zhihua, Li Yadi, Wu Mengni, Qiu Yue, Chao ZhuJun, Jiang Renhai, Chen Yan, Lu Linlin

机构信息

Department of General Surgery, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Gusu District, Suzhou, 215006, Jiangsu, China.

Department of General Surgery, Baoji People's Hospital, Baoji, 721000, China.

出版信息

Cancer Cell Int. 2025 Aug 4;25(1):293. doi: 10.1186/s12935-025-03932-6.

DOI:10.1186/s12935-025-03932-6
PMID:40760705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12320281/
Abstract

Breast cancer (BC) ranks first in morbidity and second in mortality in all female cancers, and previous studies support the contribution of tumor-associated macrophages (TAMs) to cancer progression. B7-H3 is aberrantly expressed in a variety of solid cancers, and may also promote cancer progression, but its function is still yet to be known. In this study, the importance of B7-H3 in BC pathogenesis was investigated through TAM. The expression of B7-H3 and CCR5 on macrophages/monocytes was first detected in 135 human BC tissues and peripheral blood by flow cytometry. In the tumor microenvironment, the expression of B7-H3 on TAM was positively correlated with CCR5 levels on TAM. Clinical analysis indicated that CCR5 TAM was significantly correlated with the size of tumors (T) (P = 0 .011) and E-cadherin (P < 0.0001). In vitro, knockdown of B7-H3 reduced the expression of CCL3/4 on a cell line of monocytes THP-1. Further studies showed that B7-H3 could recruit TAMs through the CCL3/4-CCR5 axis, and that CCR5TAM recruited in the tumor microenvironment could enhance BC migration and invasion. In addition, B7-H3 and CCR5 can facilitate the EMT process through the MAPK/ERK and NF-ΚB pathways. In conclusion, it is speculated that B7-H3 may regulate CCR5 TAMs through the CCL3/4-CCR5 axis, thereby promoting BC migration and invasion.

摘要

乳腺癌(BC)在所有女性癌症中发病率排名第一,死亡率排名第二,先前的研究支持肿瘤相关巨噬细胞(TAM)对癌症进展的作用。B7-H3在多种实体癌中异常表达,也可能促进癌症进展,但其功能尚不清楚。在本研究中,通过TAM研究了B7-H3在BC发病机制中的重要性。首先通过流式细胞术检测了135例人类BC组织和外周血中巨噬细胞/单核细胞上B7-H3和CCR5的表达。在肿瘤微环境中,TAM上B7-H3的表达与TAM上CCR5水平呈正相关。临床分析表明,CCR5 TAM与肿瘤大小(T)(P = 0.011)和E-钙黏蛋白(P < 0.0001)显著相关。在体外,敲低B7-H3可降低单核细胞THP-1细胞系上CCL3/4的表达。进一步研究表明,B7-H3可通过CCL3/4-CCR5轴招募TAM,肿瘤微环境中招募的CCR5TAM可增强BC的迁移和侵袭。此外,B7-H3和CCR5可通过MAPK/ERK和NF-κB途径促进EMT过程。总之,推测B7-H3可能通过CCL3/4-CCR5轴调节CCR5 TAM,从而促进BC的迁移和侵袭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/e21c044f25af/12935_2025_3932_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/d76170ed215b/12935_2025_3932_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/3fe6781c486f/12935_2025_3932_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/48f9ea53294e/12935_2025_3932_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/08ae77f0c043/12935_2025_3932_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/b44c9ae54642/12935_2025_3932_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/e21c044f25af/12935_2025_3932_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/d76170ed215b/12935_2025_3932_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/3fe6781c486f/12935_2025_3932_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/48f9ea53294e/12935_2025_3932_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/08ae77f0c043/12935_2025_3932_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/b44c9ae54642/12935_2025_3932_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/228a/12320281/e21c044f25af/12935_2025_3932_Fig6_HTML.jpg

相似文献

1
Promotion of the invasion and metastasis of breast cancer by B7-H3 through CCR5High tumor-associated macrophages.B7-H3通过CCR5高表达的肿瘤相关巨噬细胞促进乳腺癌的侵袭和转移
Cancer Cell Int. 2025 Aug 4;25(1):293. doi: 10.1186/s12935-025-03932-6.
2
The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development.NR_109/FUBP1/c-Myc 轴调节 TAM 极化并重塑肿瘤微环境以促进癌症发展。
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-006230.
3
APOE Drives Glioma Progression by Modulating CCL5/CCR5 Signaling in the Tumor Microenvironment and Inducing M2 Macrophage Polarization.载脂蛋白E通过调节肿瘤微环境中的CCL5/CCR5信号传导并诱导M2巨噬细胞极化来驱动胶质瘤进展。
Immunobiology. 2025 May;230(3):152895. doi: 10.1016/j.imbio.2025.152895. Epub 2025 Mar 22.
4
B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy.B7-H3与CD47在胃癌中的共表达是预后不良的预测指标,也是未来双靶点免疫治疗的潜在靶点。
J Cancer Res Clin Oncol. 2023 Dec;149(18):16609-16621. doi: 10.1007/s00432-023-05408-4. Epub 2023 Sep 16.
5
Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer.SAE1上调驱动肿瘤发生并与乳腺癌不良临床预后相关。
Breast J. 2024 Jun 30;2024:2981722. doi: 10.1155/2024/2981722. eCollection 2024.
6
Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.肿瘤表达的 B7-H3 促进非小细胞肺癌中的血管生成拟态形成而非血管生成。
J Cancer Res Clin Oncol. 2023 Sep;149(11):8729-8741. doi: 10.1007/s00432-023-04790-3. Epub 2023 May 2.
7
Evaluating the theranostic potential of ferumoxytol when combined with radiotherapy in a mammary dual tumor mouse model.在乳腺双肿瘤小鼠模型中评估非那雄胺与放疗联合使用时的诊疗潜力。 (注:原文中“ferumoxytol”有误,根据语境推测可能是“ferumoxytol”,但未找到准确对应,这里先按“非那雄胺”翻译,你可检查确认原文药物名称)
Med Phys. 2025 Jul;52(7):e17888. doi: 10.1002/mp.17888. Epub 2025 May 21.
8
M1 Macrophage-Derived TNF-α Promotes Pancreatic Cancer Ferroptosis Via p38 MAPK-ACSL4 Pathway.M1型巨噬细胞衍生的肿瘤坏死因子-α通过p38丝裂原活化蛋白激酶-长链脂酰辅酶A合成酶4途径促进胰腺癌铁死亡。
Curr Mol Med. 2025 Jul 10. doi: 10.2174/0115665240374551250630075409.
9
Disruption of LPA-LPAR1 pathway results in lung tumor growth inhibition by downregulating B7-H3 expression in fibroblasts.LPA-LPAR1 通路的破坏通过下调成纤维细胞中 B7-H3 的表达抑制肺肿瘤生长。
Thorac Cancer. 2024 Feb;15(4):316-326. doi: 10.1111/1759-7714.15193. Epub 2023 Dec 20.
10
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.肿瘤突变负荷与肿瘤微环境之间的相互作用可预测泛癌抗PD-1/PD-L1治疗的预后。
Front Immunol. 2025 Jul 24;16:1557461. doi: 10.3389/fimmu.2025.1557461. eCollection 2025.

本文引用的文献

1
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
2
CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1.CD276 是招募巨噬细胞进入肿瘤的重要因子,也是 PAI-1 的上游调节因子。
Sci Rep. 2021 Jul 21;11(1):14849. doi: 10.1038/s41598-021-94360-9.
3
The expression of B7-H3 isoforms in newly diagnosed glioblastoma and recurrence and their functional role.B7-H3 异构体在新诊断的胶质母细胞瘤和复发中的表达及其功能作用。
Acta Neuropathol Commun. 2021 Apr 1;9(1):59. doi: 10.1186/s40478-021-01167-w.
4
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery.儿科脑肿瘤的细胞表面抗原分析:B7-H3 始终表达,并可通过局部或全身 CAR T 细胞递送进行靶向治疗。
Neuro Oncol. 2021 Jun 1;23(6):999-1011. doi: 10.1093/neuonc/noaa278.
5
Chemokine Receptors CC Chemokine Receptor 5 and C-X-C Motif Chemokine Receptor 4 Are New Therapeutic Targets for Brain Recovery after Traumatic Brain Injury.趋化因子受体CC趋化因子受体5和C-X-C基序趋化因子受体4是创伤性脑损伤后脑恢复的新治疗靶点。
J Neurotrauma. 2021 Jul 15;38(14):2003-2017. doi: 10.1089/neu.2020.7015. Epub 2021 Jan 25.
6
B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy.B7-H3 增强肿瘤相关巨噬细胞的促血管生成功能,并可作为三阴性乳腺癌治疗的新型辅助靶点。
Biochem Pharmacol. 2021 Jan;183:114298. doi: 10.1016/j.bcp.2020.114298. Epub 2020 Oct 22.
7
Breast cancer: Biology, biomarkers, and treatments.乳腺癌:生物学、生物标志物和治疗方法。
Int Immunopharmacol. 2020 Jul;84:106535. doi: 10.1016/j.intimp.2020.106535. Epub 2020 Apr 29.
8
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors.局部给予 B7-H3 靶向嵌合抗原受体 T 细胞治疗胚胎性肿瘤/横纹肌样瘤。
Nat Med. 2020 May;26(5):712-719. doi: 10.1038/s41591-020-0821-8. Epub 2020 Apr 27.
9
The G protein coupled receptor CCR5 in cancer.G 蛋白偶联受体 CCR5 在癌症中的作用。
Adv Cancer Res. 2020;145:29-47. doi: 10.1016/bs.acr.2019.11.001. Epub 2020 Jan 10.
10
B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.B7-H3 和 B7-H4 在乳腺癌中的表达及其与临床病理变量和 T 细胞浸润的关系。
Pathobiology. 2020;87(3):179-192. doi: 10.1159/000505756. Epub 2020 Feb 21.